
==== Front
ACS OmegaACS OmegaaoacsodfACS Omega2470-1343American Chemical Society 3146027610.1021/acsomega.9b01650ArticleSustainable Synthetic
Approach for (Pyrazol-4-ylidene)pyridines By Metal Catalyst-Free Aerobic
C(sp2)–C(sp3) Coupling Reactions between
1-Amino-2-imino-pyridines and 1-Aryl-5-pyrazolones Ibrahim Hamada Mohamed *†‡Behbehani Haider *†† Chemistry
Department, Faculty of Science, Kuwait University, P.O. Box 5969, Safat 13060, Kuwait‡ Chemistry
Department, Faculty of Science, Fayoum University, P.O. Box 63514, Fayoum, Egypt* E-mail: hmi00@fayoum.edu.eg, hamadaaldeb@yahoo.com. Phone: +965-55216585. Fax: +965-248-164-82.* E-mail: drhaider.b@gmail.com. Phone: +965-55888646. Fax: +965-248-164-82.05 07 2019 31 07 2019 4 7 11701 11711 05 06 2019 21 06 2019 Copyright © 2019 American Chemical Society2019American Chemical SocietyThis is an open access article published under an ACS AuthorChoice License, which permits copying and redistribution of the article or any adaptations for non-commercial purposes.

A novel, metal catalyst-free, and efficient method has been developed
for the synthesis of (pyrazol-4-ylidene)pyridine derivatives. The
process involves dehydrogenative coupling of 1-amino-2-imino-pyridines
with 1-aryl-5-pyrazolone derivatives utilizing O2 as the
sole oxidant. The new method benefits from a high atom economy, efficiency,
and substrate scope, as well as the simplicity of reaction and product
purification procedures.

document-id-old-9ao9b01650document-id-new-14ao-2019-01650bccc-price
==== Body
Introduction
In the recent years, cross-dehydrogenative coupling (CDC) reactions
have received substantial interest. The major advancements made through
studies in this area1−10 have enabled CDC reactions to become highly attractive processes
for formation of a variety of types of bonds. Particularly, interesting
is the fact that these oxidative cross-coupling processes can be employed
to form C–C bonds between two C–H components in an intermolecular11−20 or intramolecular21−24 manner. Moreover, this approach has been extended to the formation
of C–N,25−29 C–O,30,31 C–S,32,33 S–N,34,35 C–P,36,37 and S–P38 bonds. Also, CDC reactions
have sustainable and green natures including step and atom economy,
and they avoid the need for prefunctionalization of reactants.39,40 Among the most significant C–C dehydrogenative cross-coupling
reactions are those that bring about bond formation between C(sp2)–H and C(sp3)–H centers. However,
processes of this type require activation of the less-reactive C(sp3)–H centers mainly via employment of transition-metal
catalysts such as palladium (Pd),41 copper
(Cu),42 gold (Au),43 iron (Fe),46 ruthenium (Ru),8,47 iridium (Ir),48 cobalt (Co),49 and vanadium (V),50 or nonmetal catalysts like rose bengal,51 iodine,33,52 2,3-dichloro-5,6-dicyano-1,4-benzoquinone,53 eosin,54 and phenyliodonium
diacetate55 along with suitable oxidants.

In the study described below, which is a continuation of our research
efforts focusing on pyrazole and pyridine scaffolds,44,45 we developed a metal catalyst-free protocol for the C(sp2)–C(sp3) dehydrogenative cross-coupling reactions
between 1-amino-2-imino-pyridines and 1-aryl-5-pyrazolones that produce
(pyrazol-4-ylidene)pyridine derivatives and utilize O2 as
the sole oxidant. One important benefit of the new process is that
the reactants are common, pharmaceutically important scaffolds used
in the synthesis of pharmacologically active compounds. Moreover,
the pyrazole moiety in the products is a common structural component
of substances utilized in many areas.56,57 In particular,
the pyrazole moiety is present in many organic compounds that serve
as antibacterial,58−63 antifungal,64,65 anti-inflammatory,66,67 antioxidant,68 anticancer,69−72 antituberculosis,73,74 anti-alzheimer,75 antidiabetic,76,77 antiviral,78 antimalarial,79 antileishmanial,80 and antiparkinson81 agents. Moreover, the pyridine group in the products of the new
cross-coupling reactions is a common structural feature of a wide
range of pharmaceutically and biologically active substances including
anticancer, antitumor,82−84 antiviral,85 antimicrobial,86 antidiabetic,87 antioxidant,88 anti-inflammatory,89 and antimalarial90 agents.

Results
and Discussion
Studies aimed at the development of a method for dehydrogenative
cross-coupling between the 1-amino-2-imino-pyridine and pyrazolone
derivatives commenced by exploring the reaction of 1-amino-2-imino-4-(chlorophenyl)-1,2-dihydropyridine-3-carbonitrile
(3a) and 3-methyl-1-phenyl-5-pyrazolone (4a) (Table 1). The method
used to prepare 3a and related 1-amino-2-imino-pyridine
derivatives 3b–f involves a two-step sequence
that begins with the preparation of enaminonitriles 2a–f, through reactions of the corresponding ethylidenemalononitriles 1a–f with dimethylformamide dimethylacetal (DMF–DMA)
(Scheme 1). Enaminonitriles 2a–f were then transformed to the respective targets 3a–f via thermally induced reactions with hydrazine
hydrate in ethanol (cf. Scheme 1). In the initial effort, we observed that heating a mixture
of 3a (3 mmol) and 3-methyl-1-phenyl-5-pyrazolone (4a) (3 mmol) in ethanol (10 mL) at reflux under an air atmosphere
for 24 and 48 h leads to complete recovery of the starting materials
(Table 1, entry 1).
This process failed to produce products even when carried out in the
presence of Pd(OAc)2 (10 mol %) with air or Cu(OAc)2 as oxidants (entries 2,3) and when solvents such as methanol,
acetonitrile, propanol, dioxane, toluene, and H2O are employed
(entries 4–9). In contrast, reactions of 3a (but
not with 4a) did take place to generate the corresponding
triazolo[1,5-a]pyridine derivatives 5a and 5b when N,N-dimethylformamide
(DMF) or acetic acid was used as solvents. Interestingly, when reaction
of 3a with 4a is conducted in ethanol containing
2 equiv acetic acid under an air atmosphere at 130 °C, the (pyrazol-4-ylidene)pyridine 6a is produced in a 38% yield (entry 12).

Scheme 1 Preparation of 1-Amino-2-imino-pyridine Derivatives 3a–f
Table 1 Optimization of Reaction of 1-Aminopyridine 3a and Pyrazolone 4aa
entry	catalyst	solvent	additive (equiv)	oxidant or gas	product (% yield)	
1	 	EtOH	 	Air	 	
2	Pd(OAc)2	EtOH	 	air	 	
3	Pd(OAc)2	EtOH	 	Cu(OAc)2	 	
4	- or Pd(OAc)2	MeOH	 	air or Cu(OAc)2	 	
5	- or Pd(OAc)2	CH3CN	 	air or Cu(OAc)2	 	
6	- or Pd(OAc)2	propanol	 	air or Cu(OAc)2	 	
7	- or Pd(OAc)2	1,4-dioxane	 	air or Cu(OAc)2	 	
8	- or Pd(OAc)2	toluene	 	air or Cu(OAc)2	 	
9	- or Pd(OAc)2	water	 	air or Cu(OAc)2	 	
10	- or Pd(OAc)2	DMF	 	air	5a (72)	
11	- or Pd(OAc)2	AcOH	 	air	5c (74)	
12	 	EtOH	AcOH(2)	air	6a (38)	
13	 	EtOH	AcOH(4)	air	6a (61)	
14	 	EtOH	AcOH(6)	air	6a (76)	
15	 	EtOH	AcOH(6)	O2	6a (92)	
16	 	EtOH	AcOH(6)	Ar	6a (7)	
a Reaction conditions: 1-amino-2-imino-pyridine 3a (3 mmol), pyrazolone 4a (3 mmol), in solvent
(10 mL), catalyst (10 mol % in case of using Pd(OAc)2),
oxidant air, O2 (1 atm) or (2 equiv in case of using Cu(OAc)2), and additive, at 130 °C, for 24 h.

The structure of 6a (Scheme 2) was assigned using spectral and X-ray crystallographic
data. Mass spectrometric analysis showed that 6a has
an exact mass of m/z 416.1147 and
a corresponding atomic composition of C22H17ClN6O. The 1H NMR spectrum of this substance
in dimethyl sulfoxide (DMSO) contains a singlet at 6.72 ppm (pyridine
H-5), two singlets at 7.36 and 8.64 ppm corresponding to the two NH2 moieties, and a singlet at 2.28 ppm associated with the methyl
group. The 1H NMR resonances in the 7.06–8.04 ppm
region are associated with the nine aromatic protons in 6a. Moreover, the 13C{1H} NMR spectra of 6a contain the expected 18 signals. Finally, X-ray single-crystallographic
analysis of the related (pyrazol-4-ylidene)pyridines 6b and 6k, prepared using the same general method (see
below and Figures 1 and 2), enables unambiguous assignment of
the structure of this substance. An exploratory study aimed at optimizing
the process showed that the quantity of acetic acid has an impact
on the efficiency of the process. Specifically, reactions of 3a with 4a in EtOH containing 4 or 6 equiv of
HOAc under an air atmosphere at 130 °C were found to form 6a in improved respective yields of 61 and 76% (entries 13,14).
Furthermore, when the amount of HOAc exceeds 6 equiv, the process
becomes complicated by the formation of increasing quantities of the
undesired triazolo[1,5-a]pyridine derivative 5b. Additional studies demonstrated that conducting reaction
of 3a with 4a in EtOH containing 6 equiv
of HOAc at 130 °C under an oxygen instead of air atmosphere leads
to production of 6a in a dramatically high 92% yield
(entry 15). Finally, reaction under the same conditions, except using
a degassed solvent system and an argon rather than oxygen atmosphere,
takes place to form 6a in only 7% yield (entry 16).

Figure 1 Plot of X-ray crystallographic data for 6b.

Figure 2 Plot of X-ray crystallographic data for 6k.

Scheme 2 Reactions of 1-Amino-2-imino-pyridine 3a with the Pyrazolone 4a
Having developed the optimized conditions for the new (pyrazol-4-ylidene)pyridine forming
process, we next investigated its substrate scope. For this purpose,
we probed reactions of a diverse range of 1-amino-2-imino-pyridines 3a–f, which are prepared by the sequences shown in Scheme 1 and contain either
electron-donating or electron-withdrawing 4-aryl substituents, with
several 1,3-disubstituted-pyrazolones 4a–d. The
results (Table 2) show
that the nature of substituents on the aminopyridines and pyrazolones
has little effect on the course and efficiency of the dehydrogenative
cross-coupling process. Based on the results of 1H NMR
and 13C{1H} NMR spectroscopic studies and X-ray
single-crystallographic analysis 6b and 6k (Figures 1 and 2), reactions of 3a–f with 4a–c each produce only (Z)-isomers
of the 1,2-diamino-6-(pyrazol-4-ylidene)-4-arylpyridine-3-carbonitriles 6a-s in high yields.

Table 2 Acetic Acid-Promoted Dehydrogenative Cross-Coupling
Reactions of 1-Amino-2-imino-pyridines 3a–f with
Pyrazolones 4a–da
a Reaction conditions: 1-amino-2-imino-pyridine 3a–f (3 mmol), pyrazolone 4a–d (3
mmol), in ethanol (10 mL), containing acetic acid (6 equiv), under
O2 (1 atm) at 130 °C for 24 h.

A plausible mechanism for the new (pyrazol-4-ylidene)pyridine-forming
cross-coupling reaction is displayed in Scheme 3. In the pathway, HOAc-promoted protonation
activates the 1-amino-2-imino-pyridine 3 for C-addition
of the enol form of the pyrazolone produced by HOAc-induced enolization.
The adduct A, generated in this manner, then undergoes
dehydrogenation through reaction with molecular oxygen to form the
(pyrazol-4-ylidene)pyridine 6 product.

Scheme 3 Plausible Mechanism for Formation of (Pyrazol-4-ylidene)pyridines 6 in HOAc-Promoted Dehydrogenative Cross-Coupling Reactions
of 1-Amino-2-imino-pyridines 3 with Pyrazolones 4
Finally, the utility of this CDC coupling on a laboratory preparative
scale has been probed. We observed that a gram scale (10 mmol) reaction
of 3a with 4a under the optimal conditions
produces 6a in 90% isolated yield (Scheme 4).

Scheme 4 Gram Scale Synthesis of 6a
Conclusions
In summary, in the effort discussed above, we conducted an efficient
metal catalyst-free aerobic dehydrogenative cross-coupling reaction
between the 1-amino-2-imino-pyridines and 1-aryl-5-pyrazolones, which
generates (pyrazol-4-ylidene)pyridines. The process has a high functional
group tolerance and atom economy, and it employs simple, environmentally
compatible reaction and purification procedures. As such, the protocol
should find future applications to the synthesis of these N-heterocycles of pharmaceutical and agricultural interest.

Experimental
Section
General
Melting points were recorded on a Griffin melting point apparatus
and are uncorrected. IR spectra were recorded using KBr disks using
a Jasco FT-IR-6300 spectrophotometer. 1H NMR (400 MHz)
or (600 MHz) and 13C{1H} NMR (100 MHz) or (150
MHz) spectra were recorded at 25 °C using DMSO-d6 as a solvent with TMS as the internal standard on a
Bruker DPX 400 or 600 super-conducting NMR spectrometer. Chemical
shifts (δ) are reported in ppm. Low-resolution electron impact
mass spectra [MS (EI)] and high-resolution electron impact mass spectra
[HRMS (EI)] were performed using a high-resolution GC–MS (DFS)
thermo spectrometer at 70.1 eV and a magnetic sector mass analyzer.
Following that, the courses of reactions and checking homogeneity
of products were performed using thin-layer chromatography. The X-ray
crystallographic data were collected by using a Rigaku R-AXIS RAPID
diffractometer and Bruker X8 Prospector at room temperature by using
Cu Kα radiation. The structures were solved by using direct
methods and expanded using Fourier techniques. The nonhydrogen atoms
were refined anisotropically. The structures were solved and refined
using the Bruker SHELXTL Software Package (Structure solution program-
SHELXS-97 and Refinement program- SHELXL-97).91 Data were corrected for the absorption effects using the multiscan
method (SADABS). The arylethylidenemalononitriles 1a–f(92) and enaminonitriles 2a–f(93) were prepared according to literature
procedures.

General
Procedure for the Preparation of 1-Amino-2-imino-4-aryl-1,2-dihydropyridine-3-carbonitrile 3a–f(44b)
A mixture
of the enaminonitrile 2 (20 mmol) and hydrazine hydrate
(1.5 mL, 30 mmol) in 60 mL of ethanol was stirred at reflux for 1
h. The mixture was concentrated in vacuo giving a solid that was crystallized
from the appropriate solvent to give 3 as the pure product.

1-Amino-4-(4-chlorophenyl)-2-imino-1,2-dihydropyridine-3-carbonitrile
(3a)
It is obtained as bright yellow crystals;
yield: 4.35 g (89%); mp 234–235 °C, IR (KBr) ν/cm–1: 3314, 3267 (NH2), 3178 (NH),
2210 (CN); 1H NMR (400 MHz, DMSO-d6): δ 5.89 (d, J = 6.8 Hz, 1H), 6.16
(s, 2H), 6.61 (brs, 1H), 7.61–7.63 (m, 4H), 7.81 (d, J = 6.8 Hz, 1H); 13C{1H} NMR (100
MHz, DMSO-d6): δ 101.3, 116.8, 128.8,
129.7, 134.8, 135.0, 143.1153.9, 154.3; MS (EI) m/z: (%) 246 (M+ + 2, 34.29), 245 (M+ + 1, 17.94), 244 (M+, 100); HRMS (EI) m/z: calcd for C12H9N4Cl(M+) 244.0510; found, 244.0510.

1-Amino-4-(4-bromophenyl)-2-imino-1,2-dihydropyridine-3-carbonitrile
(3b)
It is obtained as yellow crystals; yield:
5.3 g (92%); mp 239–240 °C, IR (KBr) ν/cm–1: 3311, 3263 (NH2), 3176 (NH),
2208 (CN); 1H NMR (400 MHz, DMSO-d6): δ 5.90 (d, J = 6.8 Hz, 1H), 6.17
(s, 2H), 6.73 (brs, 1H), 7.54 (d, J = 8.4 Hz, 2H),
7.74 (d, J = 8.4 Hz, 2H), 7.82 (d, J = 6.8 Hz, 1H); 13C{1H} NMR (100 MHz, DMSO-d6): δ 102.2, 116.6, 123.7, 130.0, 131.8,
135.3, 143.4, 143.4, 154.2, 154.3; MS (EI) m/z: (%) 290 (M+ + 2, 97.06), 289 (M+ + 1, 18.49), 288 (M+, 100); HRMS (EI) m/z: calcd for C12H9N4Br(M+) 288.0005; found, 288.0005.

1-Amino-4-(4-fluorophenyl)-2-imino-1,2-dihydropyridine-3-carbonitrile
(3c)
It is obtained as yellow crystals; yield:
4.35 g (89%); mp 200–201 °C, IR (KBr) ν/cm–1: 3312, 3258 (NH2), 3175 (NH),
2209 (CN); 1H NMR (600 MHz, DMSO-d6): δ 5.89 (d, J = 7.2 Hz, 1H), 6.11
(s, 2H), 6.63 (brs, 1H), 7.33–7.36 (m, 2H), 7.63–7.65
(m, 2H), 7.78 (d, J = 7.2 Hz, 1H); 13C{1H} NMR (150 MHz, DMSO-d6): δ
101.3, (115.47, 115.62) (d, 2JCF = 22.5 Hz), 116.7, (129.97, 130.03) (d, 3JCF = 9.0 Hz), 132.47, 132.49, 142.7, 153.8, 154.3, (162.01,
163.65) (d, 1JCF = 246 Hz);
MS (EI) m/z: (%) 229 (M+ + 1, 28.75), 228 (M+, 100); HRMS (EI) m/z: calcd for C12H9N4F(M+) 228.0806; found, 228.0806.

1-Amino-2-imino-4-(4-nitrophenyl)-1,2-dihydropyridine-3-carbonitrile
(3d)
It is obtained as yellow crystals; yield:
4.4 g (87%); mp 207–208 °C, IR (KBr) ν/cm–1: 3312, 3255 (NH2), 3161 (NH),
2206 (CN); 1H NMR (400 MHz, DMSO-d6): δ 5.94 (d, J = 7.2 Hz, 1H), 6.23
(brs, 2H), 6.74 (brs, 1H), 7.85–7.87 (m, 3H), 8.36 (d, J = 7.6 Hz, 2H); 13C{1H} NMR (100
MHz, DMSO-d6): δ 97.7, 101.3, 116.5,
123.9, 129.5, 142.5, 143.6, 148.2, 153.1, 154.0; MS (EI) m/z: (%) 256 (M+ + 1, 17.92), 255 (M+, 100); HRMS (EI) m/z: calcd
for C12H9N5O2(M+) 255.0751; found, 255.0750.

1-Amino-2-imino-4-phenyl-1,2-dihydropyridine-3-carbonitrile
(3e)
It is obtained as yellow crystals; yield:
3.7 g (89%); mp 165–166 °C, IR (KBr) ν/cm–1: 3318, 3226 (NH2), 3137 (NH),
2211 (CN); 1H NMR (400 MHz, DMSO-d6): δ 5.90 (d, J = 7.2 Hz, 1H), 6.16
(s, 2H), 6.53 (brs, 1H), 7.52–7.59 (m, 5H), 7.81 (d, J = 7.2 Hz, 1H); 13C{1H} NMR (100
MHz, DMSO-d6): δ 97.2, 101.6, 117.1,
127.8, 128.8, 130.1, 136.3, 143.1, 154.6, 155.1; MS (EI) m/z (%) 211 (M+ + 1, 18.25), 210 (M+, 100); HRMS (EI) m/z calcd
for C12H10N4 (M+) 210.0899;
found, 210.0899.

1-Amino-2-imino-4-p-tolyl-1,2-dihydropyridine-3-carbonitrile (3f)
It is obtained as yellow crystals; yield: 4.3 g (90%);
mp 223–224 °C, IR (KBr) ν/cm–1: 3315, 3262 (NH2), 3171 (NH), 2207 (CN); 1H NMR (400 MHz, DMSO-d6): δ
2.38 (s, 3H), 5.88 (d, J = 7.2 Hz, 1H), 6.13 (s,
2H), 6.58 (brs, 1H), 7.34 (d, J = 8.0 Hz, 2H), 7.48
(d, J = 8.0 Hz, 2H), 7.79 (d, J =
7.2 Hz, 1H); 13C{1H} NMR (100 MHz, DMSO-d6): δ 20.9, 101.6, 117.2, 127.7, 129.3,
133.3, 140.0, 142.6, 143.0, 154.6, 155.0; MS (EI) m/z (%) 225 (M+ + 1, 13.19), 224 (M+, 72.89); HRMS (EI) m/z calcd
for C13H12N4 (M+) 224.1056;
found, 224.1055.

7-(4-Chlorophenyl)[1,2,4]triazolo[1,5-a]pyridine-8-carbonitrile (5a)
It
is recrystallized from the EtOH/dioxane mixture (3:1) as yellow crystals;
yield: 0.55 g (72%), mp above 300 °C; IR (KBr) ν/cm–1: 2226 (CN); 1H NMR (600
MHz, DMSO-d6): δ 7.48 (d, J = 7.2 Hz, 1H), 7.70 (d, J = 8.4 Hz, 2H),
7.80 (d, J = 8.4 Hz, 2H), 8.75 (s, 1H), 9.35 (d, J = 7.2 Hz, 1H); 13C{1H} NMR (150
MHz, DMSO-d6): δ 97.8, 114.4, 115.4,
129.1, 130.8, 133.2, 134.2, 135.3, 148.3, 149.6, 155.5; MS (EI) m/z (%) 256 (M+ + 2, 33.19),
255 (M+ + 1, 16.29), 254 (M+, 100). HRMS (EI) m/z calcd for C13H7ClN4 (M+) 254.1147; found, 254.1147.

7-(4-Chlorophenyl)-2-methyl[1,2,4]triazolo[1,5-a]pyridine-8-carbonitrile (5b)
It
is recrystallized from the EtOH/dioxane mixture (3:1) as buff crystals;
yield: 0.6 g (74%), mp 225–226 °C; IR (KBr) ν/cm–1: 2223 (CN); 1H NMR (600
MHz, DMSO-d6): δ 2.54 (s, 3H), 7.36
(d, J = 6.8 Hz, 1H), 7.67 (d, J =
8.4 Hz, 2H), 7.76 (d, J = 8.4 Hz, 2H), 9.20 (d, J = 6.8 Hz, 1H); 13C{1H} NMR (150
MHz, DMSO-d6): δ 14.1, 96.6, 114.5,
128.7, 129.1, 130.7, 132.6, 134.3, 135.2, 147.8, 150.2, 165.1; MS
(EI): m/z (%) 270 (M+ + 2, 29.65), 269 (M+ + 1, 14.89), 268 (M+,
100). HRMS (EI): m/z calcd for C14H10ClN4 (M+) 268.1147; found, 268.1147.

General
Procedure for the Preparation of (Pyrazol-4-ylidene)pyridines Derivatives 6a–s
A mixture of the 1-amino-2-imino-pyridine 3 (3 mmol) and pyrazolone derivative 4 (3 mmol)
in ethanol (10 mL) containing acetic acid (6 equiv) under O2 (1 atm) was stirred at 130 °C for 24 h. The mixture was then
cooled to room temperature. The formed solid was collected by filtration
and recrystallized from the appropriate solvent (see below) to give
the (pyrazol-4-ylidene)pyridine 6.

(Z)-1,2-Diamino-4-(4-chlorophenyl)-6-(3-methyl-5-oxo-1-phenyl-1H-pyrazol-4(5H)-ylidene)-1,6-dihydropyridine-3-carbonitrile
(6a)
It is recrystallized from the EtOH/dioxane
mixture (1:2) as deep orange crystals; yield: 1.15 g (92%), mp above
300 °C; IR (KBr) ν/cm–1: 3338, 3298, 3262, 3237 (2NH2), 2213 (CN), 1659
(CO); 1H NMR (600 MHz, DMSO-d6): δ 2.28 (s, 3H), 6.72 (s, 1H), 7.08 (t, J = 7.8 Hz, 1H), 7.34–7.36 (m, 4H), 7.66 (d, J = 8.4 Hz, 2H), 7.71 (d, J = 8.4 Hz, 2H), 8.03 (d, J = 7.8 Hz, 2H), 8.64 (s, 2H); 13C{1H} NMR (150 MHz, DMSO-d6): δ 15.7,
82.7, 96.2, 110.5, 115.3, 118.3, 123.2, 128.4, 128.9, 130.2, 134.5,
135,3, 140.0, 146.6, 151.8, 153.8, 157.3, 162.4; MS (EI): m/z (%) 417 (M+ + 1, 34.78),
416 (M+, 100). HRMS (EI): m/z calcd for
C22H17ClN6O (M+) 416.1147;
found, 416.1147.

(Z)-1,2-Diamino-4-(4-bromophenyl)-6-(3-methyl-5-oxo-1-phenyl-1H-pyrazol-4(5H)-ylidene)-1,6-dihydropyridine-3-carbonitrile
(6b)
It is recrystallized from the EtOH/dioxane
mixture (1:1) or from aqueous DMSO for the X-ray single crystal as
orange crystals; yield: 1.3 g (94%), mp 296–297 °C; IR
(KBr) ν/cm–1: 3371,
3316, 3244, 3102 (2NH2), 2216 (CN), 1664 (CO); 1H NMR (600 MHz, DMSO-d6): δ
2.29 (s, 3H), 6.73 (s, 1H), 7.09 (t, J = 7.8 Hz,
1H), 7.35–7.37 (m, 4H), 7.64 (d, J = 7.8 Hz,
2H), 7.80 (d, J = 7.8 Hz, 2H), 8.04 (d, J = 7.8 Hz, 2H), 8.65 (s, 2H); 13C{1H} NMR (150
MHz, DMSO-d6): δ 15.7, 82.6, 96.2,
110.4, 115.3, 118.3, 123.2, 124.1, 128.4, 130.4, 131.9, 134.9, 140.0,
146.6, 151.8, 153.8, 157.3, 162.4; MS (EI): m/z (%) 462 (M+ + 2, 100), 461 (M+ +
1, 27.15), 460 (M+, 97.98). HRMS (EI): m/z calcd for C22H17BrN6O (M+) 460.0642; found, 460.0643. Crystal Data, moiety formula: 2(C22H17BrN6O), H2O, M = 940.65, monoclinic, a = 17.61(2) Å, b = 7.593(6) Å, c = 15.88(2) Å, V = 2007(3) Å3, α = γ = 90°,
β = 109.057(9)°, space group: P2/c (#13), Z = 2, Dcalc = 1.556 g·cm–3, no. of reflection
measured 3482, 2θmax = 50.1°, R1 = 0.0694 (CCDC
1889196).95

(Z)-1,2-Diamino-4-(4-fluorophenyl)-6-(3-methyl-5-oxo-1-phenyl-1H-pyrazol-4(5H)-ylidene)-1,6-dihydropyridine-3-carbonitrile
(6c)
It is recrystallized from the EtOH/dioxane
mixture (1:1) as deep orange crystals; yield: 1.05 g (88%), mp above
300 °C; IR (KBr) ν/cm–1: 3325, 3284, 3231, 3145 (2NH2), 2215 (CN), 1661
(CO); 1H NMR (600 MHz, DMSO-d6): δ 2.28 (s, 3H), 6.72 (s, 1H), 7.08 (t, J = 7.2 Hz, 1H), 7.34–7.37 (m, 4H), 7.42 (t, J = 7.2 Hz, 2H), 7.75–7.77 (m, 2H), 8.04 (d, J = 7.2 Hz, 2H), 8.63 (s, 2H); 13C{1H} NMR (150
MHz, DMSO-d6): δ 15.7, 82.8, 96.1,
110.6, 115.4, (115.87, 116.01) (d, 2JCF = 21.0 Hz), 118.3, 123.2, 128.5, (130.80, 130.86) (d, 3JCF = 9.0 Hz), 132.1, 140.0, 146.6,
152.0, 153.7, 157.3, 162.4, (162.48, 164.12) (d, 1JCF = 246 Hz); MS (EI): m/z (%) 401 (M+ + 1, 3.97), 400 (M+,
13.05), 385 (M+ – 15, 100). HRMS (EI): m/z calcd for C22H17FN6O (M+) 400.1442; found, 400.1442.

(Z)-1,2-Diamino-6-(3-methyl-5-oxo-1-phenyl-1H-pyrazol-4(5H)-ylidene)-4-(4-nitrophenyl)-1,6-dihydropyridine-3-carbonitrile
(6d)
It is recrystallized from the EtOH/dioxane
mixture (1:1) as orange crystals; yield: 1.14 g (89%), mp above 300
°C; IR (KBr) ν/cm–1: 3449,
3370, 3278, 3215 (2NH2), 2212 (CN), 1638 (CO); 1H NMR (600 MHz, DMSO-d6): δ
2.29 (s, 3H), 6.78 (s, 1H), 7.08 (t, J = 7.8 Hz,
1H), 7.35–7.37 (m, 4H), 7.96 (d, J = 9.0 Hz,
2H), 8.03 (d, J = 7.8 Hz, 2H), 8.40 (d, J = 9.0 Hz, 2H), 8.72 (s, 2H); 13C{1H} NMR (150
MHz, DMSO-d6): δ 15.7, 82.6, 96.5,
110.6, 115.1, 118.3, 123.2, 123.9, 128.5, 130.0, 139.9, 142.0, 146.7,
148.4, 150.8, 153.9, 157.2, 162.4; MS (EI): m/z (%) 428 (M+ + 1, 27.85), 427 (M+, 100). HRMS (EI): m/z calcd for C22H17N7O3 (M+) 427.1387; found,
427.1387.

(Z)-1,2-Diamino-6-(3-methyl-5-oxo-1-phenyl-1H-pyrazol-4(5H)-ylidene)-4-phenyl-1,6-dihydropyridine-3-carbonitrile
(6e)
It is recrystallized from the EtOH/dioxane
mixture (3:1) as orange crystals; yield: 0.90 g (79%), mp 252–253
°C; IR (KBr) ν/cm–1: 3354,
3291, 3249, 3198 (2NH2), 2214 (CN), 1661 (CO); 1H NMR (600 MHz, DMSO-d6): δ
2.29 (s, 3H), 6.72 (s, 1H), 7.07 (t, J = 7.8 Hz,
1H), 7.34–7.36 (m, 4H), 7.51–7.68 (m, 5H), 8.05 (d, J = 7.8 Hz, 2H), 8.59 (s, 2H); 13C{1H} NMR (150 MHz, DMSO-d6): δ 15.7,
82.8, 96.0, 110.5, 115.4, 118.3, 123.1, 128.2, 128.9, 130.4, 132.9,
135.7, 140.0, 146.6, 153.1, 153.7, 157.3, 162.4; MS (EI): m/z (%) 383 (M+ + 1, 41.89),
382 (M+, 94.08), 367 (M+ – 15, 100).
HRMS (EI): m/z calcd for C22H18N6O (M+) 382.1537; found, 382.1536.

(Z)-1,2-Diamino-4-(4-chlorophenyl)-6-(3-methyl-5-oxo-1-p-tolyl-1H-pyrazol-4(5H)-ylidene)-1,6-dihydropyridine-3-carbonitrile (6f)
It is recrystallized from the EtOH/dioxane mixture (1:2) as orange
crystals; yield: 1.08 g (83%), mp 294–295 °C; IR (KBr) ν/cm–1: 3417, 3365, 3308, 3242
(2NH2), 2217 (CN), 1654 (CO); 1H NMR (600
MHz, DMSO-d6): δ 2.26 (s, 3H), 2.28
(s, 3H), 6.70 (s, 1H), 7.15 (d, J = 8.4 Hz, 2H),
7.38 (s, 2H), 7.65 (d, J = 9.0 Hz, 2H), 7.70 (d, J = 9.0 Hz, 2H), 7.89 (d, J = 8.4 Hz, 2H),
8.64 (s, 2H); 13C{1H} NMR (150 MHz, DMSO-d6): δ 15.7, 20.5, 82.5, 96.2, 110.4, 115.3,
118.3, 128.8, 128.9, 130.2, 132.0, 134.5, 135.3, 137.7, 146.3, 151.6,
153.7, 157.3, 162.2; MS (EI): m/z (%) 432 (M+ + 2, 32.18), 431 (M+ + 1, 28.89),
430 (M+, 100). HRMS (EI): m/z calcd for
C23H19ClN6O (M+) 430.1303;
found, 430.1302.

(Z)-1,2-Diamino-4-(4-bromophenyl)-6-(3-methyl-5-oxo-1-p-tolyl-1H-pyrazol-4(5H)-ylidene)-1,6-dihydropyridine-3-carbonitrile (6g)
It is recrystallized from the EtOH/dioxane mixture (1:2) as orange
crystals; yield: 1.22 g (86%), mp 299–300 °C; IR (KBr) ν/cm–1: 3370, 3295, 3210, 3104
(2NH2), 2216 (CN), 1661 (CO); 1H NMR (600
MHz, DMSO-d6): δ 2.26 (s, 3H), 2.28
(s, 3H), 6.70 (s, 1H), 7.15 (d, J = 8.4 Hz, 2H),
7.37 (s, 2H), 7.62 (d, J = 8.4 Hz, 2H), 7.78 (d, J = 8.4 Hz, 2H), 7.88 (d, J = 8.4 Hz, 2H),
8.62 (s, 2H); 13C{1H} NMR (150 MHz, DMSO-d6): δ 15.7, 20.5, 82.5, 96.3, 110.4, 115.4,
118.3, 124.1, 128.9, 130.4, 131.9, 132.1, 134.9, 137.7, 146.3, 151.7,
153.8, 157.3, 162.2; MS (EI): m/z (%) 476 (M+ + 2, 42.39), 475 (M+ + 1, 12.75),
474 (M+, 43.18), 461 (100). HRMS (EI): m/z calcd for C23H19BrN6O (M+) 474.0798; found, 474.0798.

(Z)-1,2-Diamino-4-(fluorophenyl)-6-(3-methyl-5-oxo-1-p-tolyl-1H-pyrazol-4(5H)-ylidene)-1,6-dihydropyridine-3-carbonitrile (6h)
It is recrystallized from the EtOH/dioxane mixture (1:1) as orange
crystals; yield: 0.98 g (79%), mp 280–281 °C; IR (KBr) ν/cm–1: 3365, 3280, 3228, 3115
(2NH2), 2214 (CN), 1658 cm–1 (CO); 1H NMR (600 MHz, DMSO-d6): δ
2.27 (s, 3H), 2.29 (s, 3H), 6.71 (s, 1H), 7.15 (d, J = 7.8 Hz, 2H), 7.26 (d, J = 8.4 Hz, 2H), 7.37 (s,
2H), 7.64 (d, J = 8.4 Hz, 2H), 7.89 (d, J = 7.8 Hz, 2H), 8.61 (s, 2H); 13C{1H} NMR (150
MHz, DMSO-d6): δ 15.7, 20.5, 82.5,
96.2, 110.5, 115.4, (115.93, 116.09) (d, 2JCF = 24.0 Hz), 118.3, 123.9, 128.7, (130.56, 130.64) (d, 3JCF = 12.0 Hz), 132.0, 139.0,
145.9, 151.9, 153.8, 157.3, 162.2, (162.55, 164.21) (d, 1JCF = 249 Hz); MS (EI): m/z (%) 415 (M+ + 1, 16.88), 414 (M+, 60.97), 399 (M+ – 15, 100). HRMS (EI): m/z calcd for C23H19FN6O (M+) 414.1599; found, 414.1598.

(Z)-1,2-Diamino-6-(3-methyl-5-oxo-1-p-tolyl-1H-pyrazol-4(5H)-ylidene)-4-(4-nitrophenyl)-1,6-dihydropyridine-3-carbonitrile
(6i)
It is recrystallized from the EtOH/dioxane
mixture (2:1) as reddish brown crystals; yield: 0.97 g (74%), mp 272–273
°C; IR (KBr) ν/cm–1: 3422,
3358, 3287, 3206 (2NH2), 2216 (CN), 1657 (CO); 1H NMR (600 MHz, DMSO-d6): δ
2.27 (s, 3H), 2.28 (s, 3H), 6.77 (s, 1H), 7.16 (d, J = 8.4 Hz, 2H), 7.38 (s, 2H), 7.89 (d, J = 8.4 Hz,
2H), 7.95 (d, J = 8.4 Hz, 2H), 8.40 (d, J = 8.4 Hz, 2H), 8.70 (s, 2H); 13C{1H} NMR (150
MHz, DMSO-d6): δ 15.7, 20.4, 82.3,
96.5, 110.6, 115.1, 118.3, 123.9, 128.8, 129.9, 132.1, 137.6, 142.0,
146.3, 148.4, 150.6, 153.9, 157.2, 162.2; MS (EI): m/z (%) 442 (M+ + 1, 15.62), 441 (M+, 56.18), 426 (M+ – 15, 100). HRMS (EI): m/z calcd for C23H19N7O3 (M+) 441.1544; found, 441.1545.

(Z)-1,2-Diamino-6-(3-methyl-5-oxo-1-p-tolyl-1H-pyrazol-4(5H)-ylidene)-4-phenyl-1,6-dihydropyridine-3-carbonitrile
(6j)
It is recrystallized from the EtOH/dioxane
mixture (1:1) as orange crystals; yield: 0.95 g (81%), mp 286–287
°C; IR (KBr) ν/cm–1: 3408,
3345, 3289, 3133 (2NH2), 2220 (CN), 1655 (CO); 1H NMR (600 MHz, DMSO-d6): δ
2.27 (s, 3H), 2.28 (s, 3H), 6.71 (s, 1H), 7.15 (d, J = 8.4 Hz, 2H), 7.38 (s, 2H), 7.58–7.59 (m, 3H), 7.68–7.69
(m, 2H), 7.90 (d, J = 8.4 Hz, 2H), 8.60 (s, 2H); 13C{1H} NMR (150 MHz, DMSO-d6): δ 15.7, 20.5, 82.6, 96.1, 110.5, 115.5, 118.3, 128.2,
128.8, 128.9, 130.4, 132.0, 135.7, 137.7, 146.2, 152.9, 153.7, 157.4,
162.2; MS (EI): m/z (%) 397 (M+ + 1, 14.08), 396 (M+, 51.14). HRMS (EI): m/z calcd for C23H20N6O
(M+) 396.1693; found, 396.1694.

(Z)-1,2-Diamino-6-(3-methyl-5-oxo-1-p-tolyl-1H-pyrazol-4(5H)-ylidene)-4-p-tolyl-1,6-dihydropyridine-3-carbonitrile (6k)
It is recrystallized from the MeOH/dioxane mixture (1:2) as orange
crystals; yield: 0.92 g (75%), mp above 300 °C; IR (KBr) ν/cm–1: 3378, 3328, 3260, 3172
(2NH2), 2213 (CN), 1641 (CO); 1H NMR (600
MHz, DMSO-d6): δ 2.27 (s, 3H), 2.28
(s, 3H), 2.40 (s, 3H), 6.68 (s, 1H), 7.15 (d, J =
8.4 Hz, 2H), 7.37 (s, 2H), 7.39 (d, J = 8.4 Hz, 2H),
7.58 (d, J = 8.4 Hz, 2H), 7.90 (d, J = 8.4 Hz, 2H),8.56 (s, 2H); 13C{1H} NMR (150
MHz, DMSO-d6): δ 15.7, 20.4, 20.9,
82.5, 96.0, 110.3, 115.6, 118.3, 128.2, 128.8, 129.5, 132.0, 132.9,
137.7, 140.4, 146.2, 153.0, 157.4, 162.2; MS (EI): m/z (%) 411 (M+ + 1, 9.05), 410 (M+, 31.22), 395 (M+ – 15, 100). HRMS (EI): m/z calcd for C24H22N6O
(M+) 410.1850; found, 410.1849. Crystal Data, moiety formula:
C24H22N6O, M = 410.48, monoclinic, a = 24.0794(10) Å, b = 4.5338(2) Å, c = 19.1155(7) Å, V = 2085.15(15)
Å3, α = γ = 90°, β = 92.320(3)°,
space group: P21/c, Z = 4, Dcalc = 1.308 g·cm–3, no. of reflection measured 3640, θmax = 66.333°,
R1 = 0.0565 (CCDC 1889196).95

(Z)-1,2-Diamino-4-(4-chlorophenyl)-6-[1-(4-chlorophenyl)-3-methyl-5-oxo-1H-pyrazol-4(5H)-ylidene]-1,6-dihydropyridine-3-carbonitrile
(6l)
It is recrystallized from the EtOH/dioxane
mixture (1:2) as deep orange crystals; yield: 1.20 g (89%), mp above
300 °C; IR (KBr) ν/cm–1: 3399, 3298, 3185, 3092 (2NH2), 2217 (CN), 1665
(CO); 1H NMR (600 MHz, DMSO-d6): δ 2.27 (s, 3H), 6.72 (s, 1H), 7.31 (s, 2H), 7.40
(d, J = 8.4 Hz, 2H), 7.60 (d, J =
7.8 Hz, 2H), 7.70 (d, J = 7.8 Hz, 2H), 8.08 (d, J = 8.4 Hz, 2H), 8.67 (s, 2H); 13C{1H} NMR (150 MHz, DMSO-d6): δ 15.6,
83.1, 96.0, 110.6, 115.2, 119.5, 126.8, 128.4, 128.9, 130.2, 134.4,
135,4, 138.9, 147.2, 152.0, 153.7, 157.3, 162.4; MS (EI): m/z (%) 452 (M+ + 2, 61.23),
451 (M+ + 1, 24.98), 450 (M+, 100). HRMS (EI): m/z calcd for C22H16Cl2N6O (M+) 450.0757; found, 450.0757.

(Z)-1,2-Diamino-4-(4-bromophenyl)-6-[1-(4-chlorophenyl)-3-methyl-5-oxo-1H-pyrazol-4(5H)-ylidene]-1,6-dihydropyridine-3-carbonitrile
(6m)
It is recrystallized from the EtOH/dioxane
mixture (1:3) as deep orange crystals; yield: 1.38 g (93%), mp above
300 °C; IR (KBr) ν/cm–1: 3398, 3295, 3180, 3093 (2NH2), 2218 (CN), 1664
(CO); 1H NMR (600 MHz, DMSO-d6): δ 2.27 (s, 3H), 6.72 (s, 1H), 7.31 (s, 2H), 7.40
(d, J = 7.8 Hz, 2H), 7.63 (d, J =
7.8 Hz, 2H), 7.78 (d, J = 7.8 Hz, 2H), 8.09 (d, J = 7.8 Hz, 2H), 8.66 (s, 2H); 13C{1H} NMR (150 MHz, DMSO-d6): δ 15.6,
83.0, 96.0, 110.5, 115.2, 119.4, 124.1, 126.8, 128.4, 130.4, 131.9,
134.8, 138.9, 147.2, 152.1, 153.7, 157.2, 162.4; MS (EI): m/z (%) 496 (M+ + 2, 100), 495
(M+ + 1, 21.13), 494 (M+, 75.04). HRMS (EI): m/z calcd for C22H16BrClN6O (M+) 494.0252; found, 494.0251.

(Z)-1,2-Diamino-6-[1-(4-chlorophenyl)-3-methyl-5-oxo-1H-pyrazol-4(5H)-ylidene]-4-(4-fluorophenyl)-1,6-dihydropyridine-3-carbonitrile
(6n)
It is recrystallized from the EtOH/dioxane
mixture (1:2) as deep orange crystals; yield: 1.10 g (85%), mp above
300 °C; IR (KBr) ν/cm–1: 3394, 3293, 3190, 3111 (2NH2), 2220 (CN), 1658
(CO); 1H NMR (600 MHz, DMSO-d6): δ 2.28 (s, 3H), 6.72 (s, 1H), 7.31 (s, 2H), 7.40–7.44
(m, 4H), 7.74–7.77 (m, 2H), 8.09 (d, J = 8.4
Hz, 2H), 8.64 (s, 2H); 13C{1H} NMR (150 MHz,
DMSO-d6): δ 15.6, 83.3, 95.9, 110.6,
115.4, (115.87, 116.02) (d, 2JCF = 22.5 Hz), 119.5, 126.8, 128.4, (130.82, 130.88) (d, 3JCF = 9.0 Hz), 132.1, 138.9, 147.2, 152.2,
153.6, 157.3, 162.4, (162.50, 164.14) (d, 1JCF = 246 Hz); MS (EI): m/z (%) 435 (M+ + 1, 5.83), 434 (M+, 20.78), 419
(M+ – 15, 100). HRMS (EI): m/z calcd
for C22H16ClFN6O (M+)
434.1053; found, 434.1053.

(Z)-1,2-Diamino-6-[1-(4-chlorophenyl)-3-methyl-5-oxo-1H-pyrazol-4(5H)-ylidene]-4-(4-nitrophenyl)-1,6-dihydropyridine-3-carbonitrile
(6o)
It is recrystallized from the EtOH/dioxane
mixture (1:2) as reddish orange crystals; yield: 1.15 g (83%), mp
298–299 °C; IR (KBr) ν/cm–1: 3457, 3327, 3218, 3137 (2NH2), 2214 (CN), 1659
(CO); 1H NMR (600 MHz, DMSO-d6): δ 2.28 (s, 3H), 6.78 (s, 1H), 7.32 (s, 2H), 7.40
(d, J = 8.4 Hz, 2H), 7.95 (d, J =
8.4 Hz, 2H), 8.08 (d, J = 8.4 Hz, 2H), 8.40 (d, J = 8.4 Hz, 2H), 8.74 (s, 2H); 13C{1H} NMR (150 MHz, DMSO-d6): δ 15,
83.0, 96.3, 110.7, 115.0, 119.5, 123.9, 126.9, 128.4, 130.0, 138.8,
141.9, 147.2, 148.4, 151.0, 153.8, 157.2, 162.4; MS (EI): m/z (%) 462 (M+ + 1, 8.01),
461 (M+, 23.85), 446 (M+ – 15, 100).
HRMS (EI): m/z calcd for C22H16ClN7O3 (M+) 461.0998;
found, 461.0997.

(Z)-1,2-Diamino-6-[1-(4-chlorophenyl)-3-methyl-5-oxo-1H-pyrazol-4(5H)-ylidene]-4-phenyl-1,6-dihydropyridine-3-carbonitrile
(6p)
It is recrystallized from the EtOH/dioxane
mixture (1:1) as bright orange crystals; yield: 1.0 g (81%), mp above
300 °C; IR (KBr) ν/cm–1: 3410, 3349, 3290, 3154 (2NH2), 2208 (CN), 1656
(CO); 1H NMR (600 MHz, DMSO-d6): δ 2.28 (s, 3H), 6.72 (s, 1H), 7.31 (s, 2H), 7.41
(d, J = 9.0 Hz, 2H), 7.58–7.59 (m, 3H), 7.68–7.69
(m, 2H), 8.10 (d, J = 9.0 Hz, 2H), 8.61 (s, 2H); 13C{1H} NMR (150 MHz, DMSO-d6): δ 15.6, 83.2, 95.9, 110.6, 115.3, 119.5, 126.8, 128.3,
128.4, 128.9, 130.5, 135.6, 138.9, 147.2, 153.3, 153.6, 157.3, 162.4;
MS (EI): m/z (%) 417 (M+ + 1, 4.75), 416 (M+, 14.28), 401 (M+ –
15, 100). HRMS (EI): m/z calcd for C22H17ClN6O (M+) 416.1147; found, 416.1148.

(Z)-1,2-Diamino-4-(4-chlorophenyl)-6-(5-oxo-1,3-diphenyl-1H-pyrazol-4(5H)-ylidene)-1,6-dihydropyridine-3-carbonitrile
(6q)
It is recrystallized from the EtOH/dioxane
mixture (1:2) as red crystals; yield: 1.05 g (75%), mp 294–295
°C; IR (KBr) ν/cm–1: 3415,
3313, 3275, 3112 (2NH2), 2212 (CN), 1637 (CO); 1H NMR (600 MHz, DMSO-d6): δ
5.93 (s, 1H), 7.14 (t, J = 7.2 Hz, 1H), 7.21 (d, J = 8.4 Hz, 2H), 7.39–7.44 (m, 5H), 7.49–7.50
(m, 4H), 7.59 (d, J = 7.2 Hz, 2H), 8.10 (d, J = 8.4 Hz, 2H), 8.71 (s, 2H); 13C{1H} NMR (150 MHz, DMSO-d6): δ 83.0,
94.2, 112.6, 115.1, 118.7, 123.7, 128.2, 128.4, 128.5, 128.8, 129.5,
133.9, 134.2, 135.3, 139.9, 149.7, 150.7, 154.2, 157.2, 162.5; MS
(EI): m/z (%) 480 (M+ + 2, 35.29), 479 (M+ + 1, 31.25), 478 (M+,
100). HRMS (EI): m/z calcd for C27H19ClN6O (M+) 478.1303; found, 478.1303.

(Z)-1,2-Diamino-4-(4-bromophenyl)-6-(5-oxo-1,3-diphenyl-1H-pyrazol-4(5H)-ylidene)-1,6-dihydropyridine-3-carbonitrile
(6r)
It is recrystallized from the EtOH/dioxane
mixture (1:3) as reddish brown crystals; yield: 1.20 g (77%), mp 274–275
°C; IR (KBr) ν/cm–1: 3439,
3325, 3264, 3110 (2NH2), 2213 (CN), 1642 (CO); 1H NMR (600 MHz, DMSO-d6): δ
5.92 (s, 1H), 7.13–7.15 (m, 3H), 7.39–7.45 (m, 5H),
7.49 (s, 2H), 7.58 (d, J = 7.8 Hz, 2H), 7.63 (d, J = 8.4 Hz, 2H), 8.10 (d, J = 7.8 Hz, 2H),
8.71 (s, 2H); 13C{1H} NMR (150 MHz, DMSO-d6): δ 82.9, 94.2, 112.5, 115.1, 118.7,
123.7, 124.0, 128.2, 128.4, 128.5, 129.7, 131.7, 133.9, 134.6, 139.9,
149.8, 150.7, 154.2, 157.2, 162.5; MS (EI): m/z (%) 524 (M+ + 2, 53.68), 523 (M+ + 1, 19.25), 522 (M+, 51.17), 509 (100). HRMS (EI): m/z calcd for C27H19BrN6O (M+) 522.0798; found, 522.0797.

(Z)-1,2-Diamino-4-(4-fluorophenyl)-6-(5-oxo-1,3-diphenyl-1H-pyrazol-4(5H)-ylidene)-1,6-dihydropyridine-3-carbonitrile
(6s)
It is recrystallized from the EtOH/dioxane
mixture (1:1) as orange crystals; yield: 1.00 g (73%), mp 288–289
°C; IR (KBr) ν/cm–1: 3407,
3343, 3278, 3119 (2NH2), 2212 (CN), 1636 (CO); 1H NMR (600 MHz, DMSO-d6): δ
5.93 (s, 1H), 7.14 (t, J = 7.2 Hz, 1H), 7.23–7.28
(m, 4H), 7.39–7.46 (m, 5H), 7.49 (s, 2H), 7.59 (d, J = 7.2 Hz, 2H), 8.10 (d, J = 7.8 Hz, 2H),
8.68 (s, 2H); 13C{1H} NMR (150 MHz, DMSO-d6): δ 83.2, 94.2, 112.7, 115.3, (115.87,
116.01) (d, 2JCF = 21.0 Hz),
118.8, 123.8, 128.3, 128.5, 128.6, (130.19, 130.25) (d, 3JCF = 9.0 Hz), 131.9, 134.0, 140.0, 149.8,
151.0, 154.2, 157.3 162.6, (162.36, 164.01) (d, 1JCF = 247.5 Hz); MS (EI): m/z (%) 463 (M+ + 1, 22.08), 462 (M+, 76.02), 447 (M+ – 15, 100). HRMS (EI): m/z calcd for C27H19FN6O (M+) 462.1599; found, 462.1598.

Supporting Information Available
The Supporting Information is
available free of charge on the ACS Publications website at DOI: 10.1021/acsomega.9b01650.1H NMR, 13C{1H} NMR,
MS, and HRMS spectra for the reported compounds (PDF)

Crystal data for compound 6b (CIF)

Crystal data for compound 6k (CIF)



Supplementary Material
ao9b01650_si_001.pdf

 ao9b01650_si_002.cif

 ao9b01650_si_003.cif

 The authors declare no
competing financial interest.

Acknowledgments
Financial support for this study was provided by
Kuwait University through the research grant (SC13/18). The facilities
of Analab/SAF supported by research grants GS01/01, GS01/05, GS01/03,
and GS03/08 are gratefully acknowledged.
==== Refs
References
Kumar R. ; Kumar R. ; Chandra D. ; Sharma U. 
Cp*CoIII–catalyzed
alkylation of primary and secondary C(sp3)-H bonds of 8-alkylquinolines
with maleimides . J. Org. Chem. 
2019 , 84 , 1542 –1552 . 10.1021/acs.joc.8b02974 .30620183 
Akulov A. A. ; Varaksin M. V. ; Charushin V. N. ; Chupakhin O. N. 
Direct
functionalization of C(sp2)-H bond in nonaromatic azaheterocycles:
palladium-catalyzed cross-Dehydrogenative coupling (CDC) of 2H-imidazole
1-oxides with pyrroles and thiophenes . ACS Omega 
2019 , 4 , 825 –834 . 10.1021/acsomega.8b02916 .31459361 
Mane K. D. ; Mukherjee A. ; Vanka K. ; Suryavanshi G. 
Metal-free
regioselective cross dehydrogenative coupling of cyclic ethers and
aryl carbonyls . J. Org. Chem. 
2019 , 84 , 2039 –2047 . 10.1021/acs.joc.8b03048 .30645114 
Ren L. ; Nan G. ; Wang Y. ; Xiao Z. 
Carboxylic acid-promoted single-step
indole construction from simple anilines and ketones via aerobic cross-dehydrogenative coupling . J.
Org. Chem. 
2018 , 83 , 14472 –14488 . 10.1021/acs.joc.8b02180 .30378428 
Shaikh M. M. ; Patel A. P. ; Chikhalia K. H. 
Copper catalyzed cross-dehydrogenative
coupling (CDC) reaction of 4-thiazolidinone with terminal alkyne . Tetrahedron 
2019 , 75 , 475 –485 . 10.1016/j.tet.2018.10.068 .
Shakoor S. M. A. ; Agarwal D. S. ; Kumar A. ; Sakhuja R. 
Copper catalyzed direct
aerobic double-oxidative cross-dehydrogenative coupling of imidazoheterocycles
with aryl acetaldehydes: an articulate approach for dicarbonylation
at C-3 position . Tetrahedron 
2016 , 72 , 645 –652 . 10.1016/j.tet.2015.12.012 .
Liu X. ; Zhang J. ; Ma S. ; Ma Y. ; Wang R. 
Oxidative
cross-dehydrogenative coupling between N-aryl tetrahydroisoquinolins
and 5H-oxazol-4-ones through two methodologies: copper catalysis or
a metal-free strategy . Chem. Commun. 
2014 , 50 , 15714 –15717 . 10.1039/c4cc04508d .
Dana S. ; Chowdhury D. ; Mandal A. ; Chipem F. A. S. ; Baidya M. 
Ruthenium(II)
catalysis/noncovalent interaction synergy for cross-dehydrogenative
coupling of arene carboxylic acids . ACS Catal. 
2018 , 8 , 10173 –10179 . 10.1021/acscatal.8b03392 .
Zhang R. ; Jin S. ; Liu Q. ; Lin S. ; Yan Z. 
Transition metal-free
cross-dehydrogenative coupling reaction of coumarins with acetonitrile
or acetone . J. Org. Chem. 
2018 , 83 , 13030 –13035 . 10.1021/acs.joc.8b01508 .30295495 
Wei W. ; Wang L. ; Yue H. ; Bao P. ; Liu W. ; Hu C. ; Yang D. ; Wang H. 
Metal-free visible-light-induced
C-H/C-H cross-dehydrogenative-coupling of quinoxalin-2(H)-ones with simple ethers . ACS Sustainable
Chem. Eng. 
2018 , 6 , 17252 –17257 . 10.1021/acssuschemeng.8b04652 .
Parvatkar P. T. ; Manetsch R. ; Banik B. K. 
Metal-free cross-dehydrogenative
coupling (CDC): molecular iodine as a versatile catalyst/reagent for
CDC reactions . Chem. Asian J. 
2019 , 14 , 6 –30 . 10.1002/asia.201801237 .30259704 
Dong J. ; Xia Q. ; Lv X. ; Yan C. ; Song H. ; Liu Y. ; Wang Q. 
Photoredox-mediated direct cross-dehydrogenative coupling of heteroarenes
and amines . Org. Lett. 
2018 , 20 , 5661 –5665 . 10.1021/acs.orglett.8b02389 .30179017 
Kibriya G. ; Bagdi A. K. ; Hajra A. 
Visible-light-promoted C(sp3)-C(sp2) cross-dehydrogenative coupling of tertiary amine
with imidazopyridine . J. Org. Chem. 
2018 , 83 , 10619 –10626 . 10.1021/acs.joc.8b01433 .30132331 
Yang K. ; Bao X. ; Yao Y. ; Qu J. ; Wang B. 
Iodine-mediated cross-dehydrogenative
coupling of pyrazolones and alkenes . Org. Biomol.
Chem. 
2018 , 16 , 6275 –6283 . 10.1039/c8ob01645c .30116825 
Yang F. ; Li Y. ; Floreancig P. E. ; Li X. ; Liu L. 
Copper-catalyzed
oxidative cross-dehydrogenative coupling of 2H-chromenes and terminal
alkynes . Org. Biomol. Chem. 
2018 , 16 , 5144 –5149 . 10.1039/c8ob00949j .29963678 
Zhu Z.-Q. ; Xiao L.-J. ; Chen Y. ; Xie Z.-B. ; Zhu H.-B. ; Le Z.-G. 
A highly efficient copper(II)-catalyzed cross-dehydrogenative-coupling
reaction of N-arylglycine esters with 2-arylimidazo[1,2-a]pyridines . Synthesis 
2018 , 50 , 2775 –2783 . 10.1055/s-0036-1609845 .
Li Y. ; Peng J. ; Chen X. ; Mo B. ; Li X. ; Sun P. ; Chen C. 
Copper-catalyzed synthesis of multisubstituted indoles
through tandem Ullmann-type C–N formation and cross-dehydrogenative
coupling reactions . J. Org. Chem. 
2018 , 83 , 5288 –5294 . 10.1021/acs.joc.8b00353 .29664297 
Doan S. H. ; Nguyen V. H. H. ; Nguyen T. H. ; Pham P. H. ; Nguyen N. N. ; Phan A. N. Q. ; Tu T. N. ; Phan N. T. S. 
Cross-dehydrogenative
coupling of coumarins with Csp3-H bonds using an iron–organic
framework as a productive heterogeneous catalyst . RSC Adv. 
2018 , 8 , 10736 –10745 . 10.1039/c8ra00872h .
Wang X. ; Lei B. ; Ma L. ; Zhu L. ; Zhang X. ; Zuo H. ; Zhuang D. ; Li Z. 
Cobalt-catalyzed cross-dehydrogenative
C(sp2)-C(sp3) coupling of oxazole/thiazole with
ether or cycloalkane . Chem. Asian J. 
2017 , 12 , 2799 –2803 . 10.1002/asia.201701258 .28929591 
Zhu C. ; Zhu R. ; Zeng H. ; Chen F. ; Liu C. ; Wu W. ; Jiang H. 
Copper-catalyzed C(sp3)-H/C(sp3)-H cross-dehydrogenative
coupling with internal oxidants: synthesis of 2-trifluoromethyl-substituted
dihydropyrrol-2-ols . Angew. Chem., Int. Ed. 
2017 , 56 , 13324 –13328 . 10.1002/anie.201707719 .
Ghosh A. ; Patra A. ; Mukherjee S. ; Biju A. T. 
Synthesis of 2-aryl
naphthoquinones by the cross-dehydrogenative coupling involving an
NHC-catalyzed endo-stetter reaction . J. Org.
Chem. 
2019 , 84 , 1103 –1110 . 10.1021/acs.joc.8b02931 .30585493 
Nandwana N. K. ; Singh R. P. ; Patel O. P. S. ; Dhiman S. ; Saini H. K. ; Jha P. N. ; Kumar A. 
Design and synthesis of imidazo/benzimidazo[1,2-c]quinazoline derivatives and evaluation of their antimicrobial
activity . ACS Omega 
2018 , 3 , 16338 –16346 . 10.1021/acsomega.8b01592 .31458269 
Jiang Y.-T. ; Yu Z.-Z. ; Zhang Y.-K. ; Wang B. 
N-Bromosuccinimide-induced
C-H bond functionalization: An intramolecular cycloaromatization of
electron withdrawing group substituted 1-biphenyl-2-ylethanone for
the synthesis of 10-phenanthrenol . Org. Lett. 
2018 , 20 , 3728 –3731 . 10.1021/acs.orglett.8b01160 .29923730 
Lee A. ; Betori R. C. ; Crane E. A. ; Scheidt K. A. 
An enantioselective
cross-dehydrogenative coupling catalysis approach to substituted tetrahydropyrans . J. Am. Chem. Soc. 
2018 , 140 , 6212 –6216 . 10.1021/jacs.8b03063 .29714480 
Kramer S. 
Synthesis
of α-substituted primary benzylamines through copper-catalyzed
cross-dehydrogenative coupling . Org. Lett. 
2019 , 21 , 65 –69 . 10.1021/acs.orglett.8b03505 .30557025 
Wei W. ; Wang L. ; Bao P. ; Shao Y. ; Yue H. ; Yang D. ; Yang X. ; Zhao X. ; Wang H. 
Metal-free
C(sp2)-H/N-H cross-dehydrogenative coupling of quinoxalinones
with aliphatic amines under visible-light photoredox catalysis . Org. Lett. 
2018 , 20 , 7125 –7130 . 10.1021/acs.orglett.8b03079 .30372088 
Sun B. ; Yan Z. ; Jin C. ; Su W. 
(Diacetoxyiodo)benzene-mediated transition-metal-free
amination of C(sp3)-H bonds adjacent to heteroatoms with
azoles: synthesis of N-alkylated azoles . Synlett 
2018 , 29 , 2432 –2436 . 10.1055/s-0037-1610293 .
Kumar P. ; Sharma A. K. ; Singh R. ; Guntreddi T. ; Nand Singh K. 
Nickel catalyzed ipso-hydroxylation and Subsequent
cross dehydrogenative coupling of arylboronic acids with tertiary
amines: A facile access to α-phenolated tertiary amines . Adv. Synth. Catal. 
2018 , 360 , 1786 –1789 . 10.1002/adsc.201701625 .
Ahmad A. ; Dutta H. S. ; Khan B. ; Kant R. ; Koley D. 
Cu(I)-Catalyzed
site selective acyloxylation of indoline using O2 as the
sole oxidant . Adv. Synth. Catal. 
2018 , 360 , 1644 –1649 . 10.1002/adsc.201800040 .
Bityukov O. V. ; Matveeva O. K. ; Vil’ V. A. ; Kokorekin V. A. ; Nikishin G. I. ; Terent’ev A. O. 
Electrochemically induced intermolecular
cross-dehydrogenative C-O coupling of β-diketones and β-ketoesters
with carboxylic acids . J. Org. Chem. 
2019 , 84 , 1448 –1460 . 10.1021/acs.joc.8b02791 .30618255 
Xu X. ; Li P. ; Huang Y. ; Tong C. ; Yan Y. ; Xie Y. 
Atmospheric
oxidative catalyst-free cross-dehydrogenative coupling of aldehydes
with N-hydroxyimides . Tetrahedron
Lett. 
2017 , 58 , 1742 –1746 . 10.1016/j.tetlet.2017.03.064 .
Huang X. ; Chen Y. ; Zhen S. ; Song L. ; Gao M. ; Zhang P. ; Li H. ; Yuan B. ; Yang G. 
Cobalt-catalyzed
aerobic cross-dehydrogenative coupling of C-H and thiols in water
for C-S formation . J. Org. Chem. 
2018 , 83 , 7331 –7340 . 10.1021/acs.joc.7b02718 .29313345 
Yang D. ; Sun P. ; Wei W. ; Meng L. ; He L. ; Fang B. ; Jiang W. ; Wang H. 
Metal-free iodine-catalyzed direct
cross-dehydrogenative coupling (CDC) between pyrazoles and thiols . Org. Chem. Front. 
2016 , 3 , 1457 –1461 . 10.1039/c6qo00407e .
Rattanangkool E. ; Krailat W. ; Vilaivan T. ; Phuwapraisirisan P. ; Sukwattanasinitt M. ; Wacharasindhu S. 
Hypervalent iodine(III)-promoted
metal-free S–H activation: An approach for the construction
of S–S, S–N, and S–C bonds . Eur. J. Org. Chem. 
2014 , 2014 , 4795 –4804 . 10.1002/ejoc.201402180 .
Dou Y. ; Huang X. ; Wang H. ; Yang L. ; Li H. ; Yuan B. ; Yang G. 
Reusable cobalt-phthalocyanine in
water: Efficient catalytic aerobic oxidative coupling of thiols to
construct S–N/S–S bonds . Green
Chem. 
2017 , 19 , 2491 –2495 . 10.1039/c7gc00401j .
Deng L. ; Wang Y. ; Mei H. ; Pan Y. ; Han J. 
Electrochemical
dehydrogenative phosphorylation of alcohols for the synthesis of organophosphinates . J. Org. Chem. 
2019 , 84 , 949 –956 . 10.1021/acs.joc.8b02882 .30608670 
Liu Y. ; Liu Z. ; Zhang Y. ; Xiong C. 
Manganese(III) acetylacetonate-mediated
phosphorylation of enamides at room temperature . Adv. Synth. Catal. 
2018 , 360 , 3492 –3496 . 10.1002/adsc.201800585 .
Chang C.-Z. ; Liu X. ; Zhu H. ; Wu L. ; Dong Z.-B. 
Copper-catalyzed
and air-mediated mild cross-dehydrogenative coupling of aryl thioureas
and dialkyl H-phosphonates: The synthesis of thiophosphonates . J. Org. Chem. 
2018 , 83 , 13530 –13535 . 10.1021/acs.joc.8b02011 .30354124 
Yang Y. ; Lan J. ; You J. 
Oxidative C–H/C–H coupling reactions
between two (hetero) arenes . Chem. Rev. 
2017 , 117 , 8787 –8863 . 10.1021/acs.chemrev.6b00567 .28085272 
Song G. ; Li X. 
Substrate activation strategies in rhodium (III)-catalyzed selective
functionalization of arenes . Acc. Chem. Res. 
2015 , 48 , 1007 –1020 . 10.1021/acs.accounts.5b00077 .25844661 
Xuan J. ; Zeng T.-T. ; Feng Z.-J. ; Deng Q.-H. ; Chen J.-R. ; Lu L.-Q. ; Xiao W.-J. ; Alper H. 
Redox-neutral α-allylation
of amines by combining palladium catalysis and visible-light photoredox
catalysis . Angew. Chem., Int. Ed. 
2015 , 54 , 1625 –1628 . 10.1002/anie.201409999 .
a Wang F.-F. ; Luo C.-P. ; Deng G. ; Yang L. 
C(sp3)–C(sp3) bond formation via copper/Brønsted acid co-catalyzed C(sp3)–H bond oxidative cross-dehydrogenative-coupling (CDC) of
azaarenes . Green Chem. 
2014 , 16 , 2428 –2431 . 10.1039/c4gc00038b . b Liu X. ; Zhang J. ; Ma S. ; Ma Y. ; Wang R. 
Oxidative
cross-dehydrogenative coupling between N-aryl tetrahydroisoquinolins
and 5H-oxazol-4-ones through two methodologies: copper catalysis or
a metal-free strategy . Chem. Commun. 
2014 , 50 , 15714 –15717 . 10.1039/c4cc04508d . c Perepichka I. ; Kundu S. ; Hearne Z. ; Li C.-J. 
Efficient
merging of copper and photoredox catalysis for the asymmetric cross-dehydrogenativecoupling
of alkynes and tetrahydroisoquinolines . Org.
Biomol. Chem. 
2015 , 13 , 447 –451 . 10.1039/c4ob02138j .25372475 
Xie J. ; Li H. ; Zhou J. ; Cheng Y. ; Zhu C. 
A highly efficient
gold-catalyzed oxidative C–C coupling from C–H bonds
using air as oxidant . Angew. Chem., Int. Ed. 
2012 , 124 , 1278 –2181 . 10.1016/j.tet.2013.05.040 .
a Ratnikov M. O. ; González-Gómez X. ; Doyle M. P. 
Simple and sustainable iron-catalyzed aerobic C–H
functionalization of N,N-dialkylanilines . J. Am. Chem. Soc. 
2013 , 135 , 9475 –9479 . 10.1021/ja402479r .23734676  b Yu J.-B. ; Zhang Y. ; Jiang Z.-J. ; Su W.-K. 
Mechanically induced Fe(III) catalysis at room temperature: solvent-free
cross-dehydrogenative coupling of 3-benzylic indoles with methylenes/indoles . J. Org. Chem. 
2016 , 81 , 11514 –11520 . 10.1021/acs.joc.6b02197 .27779398 
Meng Q.-Y. ; Liu Q. ; Zhong J.-J. ; Zhang H.-H. ; Li Z.-J. ; Chen B. ; Tung C.-H. ; Wu L. Z. 
Graphene-supported RuO2 nanoparticles for efficient aerobic cross-dehydrogenative coupling
reaction in water . Org. Lett. 
2012 , 14 , 5992 –5995 . 10.1021/ol3028785 .23194402 
a Feng Z.-J. ; Xuan J. ; Xia X.-D. ; Ding W. ; Guo W. ; Chen J.-R. ; Zou Y.-Q. ; Lu L.-Q. ; Xiao W.-J. 
Direct sp3 C-H acroleination
of N-aryltetrahydroisoquinolines by merging photoredox catalysis with
nucleophilic catalysis . Org. Biomol. Chem. 
2014 , 12 , 2037 –2040 . 10.1039/c3ob42453g .24553793  b Condie A. G. ; Gozález-Gómez J. C. ; Stephenson C. R. J. 
Visible-light photoredox catalysis: aza-Henry reactions via C–H functionalization . J. Am. Chem. Soc. 
2010 , 132 , 1464 –1465 . 10.1021/ja909145y .20070079 
Li Q. ; Hu W. ; Hu R. ; Lu H. ; Li G. 
Cobalt-catalyzed cross-dehydrogenative
coupling reaction between unactivated C(sp2)-H and C(sp3)-H bonds . Org. Lett. 
2017 , 19 , 4676 –4679 . 10.1021/acs.orglett.7b02316 .28829611 
Jones K. M. ; Karier P. ; Zeitler M. 
C1-Substituted N-alkyl tetrahydroisoquinoline derivatives through V-catalyzed oxidative
coupling . ChemCatChem 
2012 , 4 , 51 –54 . 10.1002/cctc.201100324 .
a Zhong J.-J. ; Meng Q.-Y. ; Liu B. ; Li X.-B. ; Gao X.-W. ; Lei T. ; Wu C.-J. ; Li Z.-J. ; Tung C.-H. ; Wu L.-Z. 
Cross-coupling hydrogen
evolution reaction in homogeneous solution without noble metals . Org. Lett. 
2014 , 16 , 1988 –1991 . 10.1021/ol500534w .24628016  b Pan Y. ; ang S. ; Kee C. W. ; Dubuisson E. ; Yang Y. ; Loh K. P. ; Tan C.-H. 
Graphene oxide and
rose bengal: oxidative C–H functionalisation of tertiary amines
using visible light . Green Chem. 
2011 , 13 , 3341 –3344 . 10.1039/c1gc15865a .
Majji G. ; Guin S. ; Rout S. K. ; Behera A. ; Patel B. K. 
Cyclic
ethers to esters and monoesters to bis-esters with unconventional
coupling partners under metal free conditions via sp3 C–H functionalization . Chem. Commun. 
2014 , 50 , 12193 –12196 . 10.1039/c4cc05050a .
Franz J. F. ; Kraus W. B. ; Zeitler K. 
No photocatalyst required-versatile,
visible light mediated transformations with polyhalomethanes . Chem. Commun. 
2015 , 51 , 8280 –8283 . 10.1039/c4cc10270c .
Liu Q. ; Li Y.-N. ; Zhang H.-H. ; Chen B. ; Tung C.-H. ; Wu L.-Z. 
Reactivity and mechanistic insight into visible-light-induced aerobic
cross-dehydrogenative coupling reaction by organophotocatalysts . Chem.—Eur. J. 
2012 , 18 , 620 –627 . 10.1002/chem.201102299 .22162148 
Huang L. ; Zhao J. 
Iodo-Bodipys as visible-light-absorbing dual-functional photoredox
catalysts for preparation of highly functionalized organic compounds
by formation of C–C bonds via reductive and oxidative quenching
catalytic mechanisms . RSC Adv. 
2013 , 3 , 23377 –23388 . 10.1039/c3ra43299h .
a Behbehani H. ; Ibrahim H. M. 
A strategy for the
synthesis of 2-aryl-3-dimethylamino- pyrazolo[3,4-c]pyridines that
utilizes [4+1] cycloaddition reactions of 5-arylazo-2,3,6-trisubstituted
pyridines . Tetrahedron 
2013 , 69 , 10535 –10543 . 10.1016/j.tet.2013.10.061 . b Ibrahim H. M. ; Behbehani H. ; Mostafa N. S. 
Scalable sonochemical
synthetic strategy for pyrazolo[1,5-a]pyridine derivatives: First
catalyst free concerted [3+2] cycloaddition of alkyne and alkene derivatives
to 2-imino-1H-pyridin-1-amines . ACS Omega 
2019 , 4 , 7182 –7193 . 10.1021/acs.joc.6b02197 .31459824 
a Ibrahim H. M. ; Arafa W. A. A. ; Behbehani H. 
L-Proline
catalyzed one-pot synthesis of polysubstituted pyridine system incorporating
benzothiazole moiety via sustainable sonochemical approach . RSC Adv. 
2018 , 8 , 37606 –37617 . 10.1039/c8ra07013j . b Behbehani H. ; Ibrahim H. M. ; Elnagdi M. H. 
Non-concerted nucleophilic
[4+1] cycloaddition of (dimethylamino)methoxycarbene to arylazonicotinates
in the synthesis of a pyrazolo[3,4-c]pyridines and
pyrazolo[4’,3’:4,5]pyrido[2,3-d]pyrimidines . Tetrahedron 
2013 , 69 , 6176 –6184 . 10.1016/j.tet.2013.05.040 .
Fustero S. ; Sánchez-Roselló M. ; Barrio P. ; Simón-Fuentes A. 
A fruitful
decade for the synthesis of pyrazoles . Chem.
Rev. 
2011 , 111 , 6984 –7034 . 10.1021/cr2000459 .21806021 
Ansari A. ; Ali A. ; Asif M. 
biologically active pyrazole derivatives . New J. Chem. 
2017 , 41 , 16 –41 . 10.1039/c6nj03181a .
B’Bhatt H. ; Sharma S. 
Synthesis and antimicrobial activity of pyrazole nucleus
containing 2-thioxothiazolidin-4-one derivatives . Arabian J. Chem. 
2017 , 10 , S1590 –S1596 . 10.1016/j.arabjc.2013.05.029 .
Ragavan R. V. ; Vijayakumar V. ; Kumari N. S. 
Synthesis and antimicrobial activities
of novel 1,5-diaryl pyrazoles . Eur. J. Med.
Chem. 
2010 , 45 , 1173 –1180 . 10.1016/j.ejmech.2009.12.042 .20053480 
Sharma P. K. ; Chandak N. ; Kumar P. ; Sharma C. ; Aneja K. R. 
Synthesis
and biological evaluation of some 4-functionalized-pyrazoles as antimicrobial
agents . Eur. J. Med. Chem. 
2011 , 46 , 1425 –1432 . 10.1016/j.ejmech.2011.01.060 .21342734 
Pathak R. B. ; Chovatia P. T. ; Parekh H. H. 
Synthesis, antitubercular and antimicrobial
evaluation of 3-(4-chlorophenyl)-4-substituted pyrazole derivatives . Bioorg. Med. Chem. Lett. 
2012 , 22 , 5129 –5133 . 10.1016/j.bmcl.2012.05.063 .22695129 
Vijesh A. M. ; Isloor A. M. ; Telkar S. ; Peethambar S. K. ; Rai S. ; Isloor N. 
Synthesis, characterization and antimicrobial studies
of some new pyrazole incorporated imidazole derivatives . Eur. J. Med. Chem. 
2011 , 46 , 3531 –3536 . 10.1016/j.ejmech.2011.05.005 .21620535 
Kalaria P. N. ; Satasia S. P. ; Avalani J. R. ; Raval D. K. 
Ultrasound-assisted
one-pot four-component synthesis of novel 2-amino-3-cyanopyridine
derivatives bearing 5-imidazopyrazole scaffold and their biological
broadcast . Eur. J. Med. Chem. 
2014 , 83 , 655 –664 . 10.1016/j.bmcl.2015.11.038 .25010936 
Mu J.-X. ; Shi Y.-X. ; Yang M.-Y. ; Sun Z.-H. ; Liu X.-H. ; Li B.-J. ; Sun N.-B. 
Design, Synthesis, DFT Study and
antifungal activity of pyrazolecarboxamide derivatives . Molecules 
2016 , 72 , 5769 10.1016/j.tet.2016.07.078 .
Mert S. ; Kasimogullari R. ; Ica T. ; Colak F. ; Altun A. ; Ok S. 
Synthesis, structure-activity relationships, and in vitro antibacterial
and antifungal activity evaluations of novel pyrazole carboxylic and
dicarboxylic acid derivatives . Eur. J. Med.
Chem. 
2014 , 78 , 86 –96 . 10.1016/j.ejmech.2014.03.033 .24681068 
Alegaon S. G. ; Alagawadi K. R. ; Garg M. K. ; Dushyant K. ; Vinod D. 
1,3,4- Trisubstituted
pyrazole analogues as promising anti-inflammatory agents . Bioorg. Chem. 
2014 , 54 , 51 –59 . 10.1016/j.bioorg.2014.04.001 .24793214 
Sharma P. K. ; Kumar S. ; Kumar P. ; Kaushik P. ; Kaushik D. ; Dhingra Y. 
Synthesis and biological evaluation of some pyrazolylpyrazolines
as anti-inflammatory–antimicrobial agents . Eur. J. Med. Chem. 
2010 , 45 , 2650 –2655 . 10.1016/j.ejmech.2010.01.059 .20171763 
Nagamallu R. ; Srinivasan B. ; Ningappa M. B. ; Kariyappa A. K. 
of novel
coumarin appended bis(formylpyrazole) derivatives: Studies on their
antimicrobial and antioxidant activities . Bioorg.
Med. Chem. Lett. 
2016 , 26 , 690 –694 . 10.1016/j.bmcl.2015.11.038 .26631319 
Wang F.-Q. ; O’Keefe H. ; He B. ; Remuiñán Y.-K. ; Meng S.-Y. ; Zhang C. ; Liu H.-M. ; Pérez-Macías F.-W. 
A novel
domino approach for synthesis of indolyl tetrahydropyrano[4,3-c]pyrazole derivatives as anticancer agents . Tetrahedron 
2016 , 72 , 5769 –5775 . 10.1016/j.tet.2016.07.078 .
Shi W. ; Hu J. ; Bao N. ; Li D. ; Chen L. ; Sun J. 
Design, synthesis
and cytotoxic activities of scopoletin-isoxazole and scopoletin-pyrazole
hybrids . Bioorg. Med. Chem. Lett. 
2017 , 27 , 147 –151 . 10.1016/j.bmcl.2016.11.089 .27956344 
Wen J. ; Bao Y. ; Niu Q. ; Yang J. ; Fan Y. ; Li J. ; Jing Y. ; Zhao L. ; Liu D. 
of N-(6-mercaptohexyl)-3-(4-pyridyl)-1H-pyrazole-5-carboxamide
and its disulfide prodrug as potent histone deacetylase inhibitors
with in vitro and in vivo anti-tumor efficacy . Eur. J. Med. Chem. 
2016 , 109 , 350 –359 . 10.1016/j.ejmech.2016.01.013 .26814680 
Wang M. ; Xu S. ; Lei H. ; Wang C. ; Xiao Z. ; Jia S. ; Zhi J. ; Zheng P. ; Zhu W. 
Design, synthesis and antitumor activity
of novel sorafenib derivatives bearing pyrazole scaffold . Bioorg. Med. Chem. 
2017 , 25 , 5754 –5763 . 10.1016/j.bmc.2017.09.003 .28927801 
Ramesh R. ; Shingare R. D. ; Kumar V. ; Anand A. ; Swetha B. ; Veeraraghavan S. ; Viswanadha S. ; Ummanni R. ; Gokhale R. ; Reddy D. S. 
Repurposing of a drug scaffold: Identification of novel
sila analogues of rimonabant as potent antitubercular agents . Eur. J. Med. Chem. 
2016 , 122 , 723 –730 . 10.1016/j.ejmech.2016.07.009 .27476117 
Encinas L. ; O’Keefe H. ; Neu M. ; Remuiñán M. J. ; Patel A. M. ; Guardia A. ; Davie C. P. ; Pérez-Macías N. ; Yang H. ; Convery M. A. 
Encoded library technology as a source
of hits for the discovery and lead optimization of a potent and selective
class of bactericidal direct inhibitors of mycobacterium tuberculosis
InhA . J. Med. Chem. 
2014 , 57 , 1276 –1288 . 10.1021/jm401326j .24450589 
Malamas M. S. ; Erdei J. ; Gunawan I. ; Barnes K. ; Hui Y. ; Johnson M. ; Robichaud A. ; Zhou P. ; Yan Y. ; Solvibile W. 
New pyrazolyl and thienyl aminohydantoins as potent
BACE1 inhibitors: Exploring the S2′ region . Bioorg. Med. Chem. Lett. 
2011 , 21 , 5164 –5170 . 10.1016/j.bmcl.2011.07.057 .21835615 
Toda N. ; Hao X. ; Ogawa Y. ; Oda K. ; Yu M. ; Fu Z. ; Chen Y. ; Kim Y. ; Lizarzaburu M. ; Lively S. ; Lawlis S. ; Murakoshi M. ; Nara F. ; Watanabe N. ; Reagan J. D. ; Tian H. ; Fu A. ; Motani A. ; Liu Q. ; Lin Y.-J. ; Zhuang R. ; Xiong Y. ; Fan P. ; Medina J. ; Li L. ; Izumi M. ; Okuyama R. ; Shibuya S. 
and orally bioavailable
GPR142 agonists as novel insulin secretagogues for the treatment of
type 2 diabetes . ACS Med. Chem. Lett. 
2013 , 4 , 790 –794 . 10.1021/ml400186z .24900747 
Chaudhry F. ; Naureen S. ; Huma R. ; Shaukat A. ; Al-Rashida M. ; Asif N. ; Ashraf M. ; Munawar M. A. ; Khan M. A. 
In search
of new α-glucosidase inhibitors: Imidazolylpyrazole derivatives . Bioorg. Chem. 
2017 , 71 , 102 –109 . 10.1016/j.bioorg.2017.01.017 .28160945 
Jia H. ; Bai F. ; Liu N. ; Liang X. ; Zhan P. ; Ma C. ; Jiang X. ; Liu X. 
Design, synthesis and evaluation
of pyrazole derivatives as non-nucleoside hepatitis B virus inhibitors . Eur. J. Med. Chem. 
2016 , 123 , 202 –210 . 10.1016/j.ejmech.2016.07.048 .27484509 
González C. D. ; Douelle F. ; Feng T.-S. ; Nchinda A. T. ; Younis Y. ; White K. L. ; Wu Q. ; Ryan E. ; Burrows J. N. ; Waterson D. 
Novel orally active antimalarial thiazoles . J. Med. Chem. 
2011 , 54 , 7713 –7719 . 10.1021/jm201108k .21966980 
Bekhit A. A. ; Hassan A. M. ; Abd El Razik H. A. ; El-Miligy M. M. ; El-Agroudy E. J. ; Bekhit́ A. D. 
New heterocyclic hybrids of pyrazole
and its bioisosteres: Design, synthesis and biological evaluation
as dual acting antimalarial-antileishmanial agents . Eur. J. Med. Chem. 
2015 , 94 , 30 –44 . 10.1016/j.ejmech.2015.02.038 .25768697 
Estrada A. A. ; Chan B. K. ; Baker-Glenn C. ; Beresford A. ; Burdick D. J. ; Chambers M. ; Chen H. ; Dominguez S. L. ; Dotson J. ; Drummond J. ; Flagella M. ; Fuji R. ; Gill A. ; Halladay J. ; Harris S. F. ; Heffron T. P. ; Kleinheinz T. ; Lee D. W. ; Le Pichon C. E. ; Liu X. ; Lyssikatos J. P. ; Medhurst A. D. ; Moffat J. G. ; Nash K. ; Scearce-Levie K. ; Sheng Z. ; Shore D. G. ; Wong S. ; Zhang X. ; Zhu H. ; Sweeney Z. K. 
Discovery
of highly potent, selective, and brain-penetrant aminopyrazole leucine-rich
repeat kinase 2 (LRRK2) small molecule inhibitors . J. Med. Chem. 
2014 , 57 , 921 –936 . 10.1021/jm401654j .24354345 
Easmon J. ; Pürstinger G. ; Thies K.-S. ; Heinisch G. ; Hofmann J. 
Synthesis,
Structure-activity relationships, and antitumor studies of 2-benzoxazolyl
hydrazones derived from alpha-(N)-acyl heteroaromatics . Med. Chem. 
2006 , 49 , 6343 –6350 . 10.1021/jm060232u .
Kumar G. S. ; Poornachandra Y. ; Gunda S. K. ; Reddy K. R. ; Mohmed J. ; Shaik K. ; Kumar C. G. ; Narsaiah B. 
Synthesis of novel
hetero ring fused pyridine derivatives; Their anticancer activity,
CoMFA and CoMSIA studies . Bioorg. Med. Chem.
Lett. 
2018 , 28 , 2328 –2337 . 10.1016/j.bmcl.2018.04.031 .29798826 
Wei M. ; Peng X. ; Xing L. ; Dai Y. ; Huang R. ; Geng M. ; Zhang A. ; Ai J. ; Song Z. 
Design, synthesis
and biological evaluation of a series of novel 2-benzamide-4-(6-oxy-N-methyl-1-naphthamide)pyridine derivatives as potent fibroblast
growth factor receptor (FGFR) inhibitors . Eur.
J. Med. Chem. 
2018 , 154 , 9 –28 . 10.1016/j.ejmech.2018.05.005 .29775937 
Vrábel M. ; Hocek M. ; Havran L. ; Fojta M. ; Votruba I. ; Klepetařova B. ; Pohl R. ; Rulišek L. ; Zendlova L. ; Hobza P. ; Shih I. H. ; Mabery E. ; Mackman R. 
Purines bearing phenanthroline or bipyridine ligands
and their RuII complexes in position 8 as model compounds for electrochemical
DNA labeling–synthesis, crystal structure, electrochemistry,
quantum chemical calculations, cytostatic and antiviral activity . Eur. J. Inorg. Chem. 
2007 , 1752 –1769 . 10.1002/ejic.200700030 .
Carreno A. ; Zuniga C. ; Paez-Hernandez D. ; Gacitua M. ; Polanco R. ; Otero C. ; Arratia-Perez R. ; Fuentes J. A. 
Study of the structure–bioactivity
relationship of three new pyridine Schiff bases: synthesis, spectral
characterization, DFT calculations and biological assays . New J. Chem. 
2018 , 64 , 8851 –8863 . 10.1039/c8nj00390d .
Riaz S. ; Khan I. U. ; Bajda M. ; Ashraf M. ; Ain Q. ; Shaukat A. ; Ur Rehman T. ; Mutahir S. ; Hussain S. ; Mustafa G. ; Yar M. 
Pyridine sulfonamide as a small key
organic molecule for the potential treatment of type-II diabetes mellitus
and Alzheimer’s disease: In vitro studies against yeast α-glucosidase,
acetylcholinesterase and butyrylcholinesterase . Bioorg. Chem. 
2015 , 63 , 64 –71 . 10.1016/j.bioorg.2015.09.008 .26451651 
Worachartcheewan A. ; Prachayasittikul S. ; Pingaew R. ; Nantasenamat C. ; Tantimongcolwat T. ; Ruchirawat S. ; Prachayasittikul V. 
Antioxidant,
cytotoxicity, and QSAR study of 1-adamantylthio derivatives of 3-picoline
and phenylpyridines . Med. Chem. Res. 
2012 , 21 , 3514 –3522 . 10.1007/s00044-011-9903-y .
Nechipadappu S. K. ; Trivedi D. R. 
Structural and physicochemical characterization of
pyridine derivative salts of anti-inflammatory drugs . J. Mol. Struct. 
2017 , 1141 , 64 –74 . 10.1021/acsomega.9b00562 .
Chapman T. M. ; Osborne S. A. ; Wallace C. ; Birchall K. ; Bouloc N. ; Jones H. M. ; Ansell K. H. ; Taylor D. L. ; Clough B. ; Green J. L. ; Holder A. A. 
Optimization of an imidazopyridazine
series of inhibitors of plasmodium falciparum calcium-dependent protein
kinase 1 (PfCDPK1) . J. Med. Chem. 
2014 , 57 , 3570 –3587 . 10.1021/jm500342d .24689770 
Sheldrick G. M. 
A short
history of SHELX . Acta Crystallogr. 
2008 , 64 , 112 –122 . 10.1107/s0108767307043930 .
Longstreet A. R. ; Campbell B. S. ; Gupton B. F. ; McQuade D. T. 
Improved synthesis
of mono- and disubstituted 2-halonicotinonitriles from alkylidene
malononitriles . Org. Lett. 
2013 , 15 , 5298 –5301 . 10.1021/ol4025265 .24093933 
Villemin D. ; Belhadj Z. ; Cheikh N. ; Choukchou-Braham N. ; Bar N. ; Lohier J.-F. 
Solventlesso-2-aminopyridine derivatives from enaminonitriles . Tetrahedron Lett. 
2013 , 54 , 1664 –1668 . 10.1016/j.tetlet.2013.01.021 .
The crystallographic data for 6b (ref. CCDC 1910269) and 6k (ref. CCDC 1910270) can
be obtained on request from the director, Cambridge Crystallographic
Data Center, 12 Union Road, Cambridge CB2 1EW, UK.

